This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
First quarter revenues of $2.61 billion, down 4.0% from 2021 First quarter reported diluted earnings per share ("EPS") of $2.92, down 15.6% from 2021; and adjusted diluted EPS of $3.22, down 14.4%...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has made several organizational changes and leadership appointments of seasoned...
New Capability Enables Individuals Identified as High-Risk by Participating Health Plans to Access Screening through a Quest Diagnostics Site Builds on Quest's Extended Care Services to Improve...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2022 financial results on Thursday, April...
Positivity for Cocaine and Marijuana Increase for Federally Mandated, Safety-Sensitive Workers Required to Test Under Federal Law Amid Widespread Recruiting and Retention Challenges, Drug...